Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
16.05. | Zero Candida Technologies Inc: Zero Candida appoints Kostioutchenko as director | 1 | Stockwatch | ||
ZERO CANDIDA TECHNOLOGIES Aktie jetzt für 0€ handeln | |||||
02.04. | Zero Candida Technologies reports FY results | 1 | Seeking Alpha | ||
02.04. | Zero Candida Technologies Reports Full Year 2024 Financial Results and Business Highlights | 183 | PR Newswire | VANCOUVER, BC, April 2, 2025 /PRNewswire/ -- Zero Candida Technologies, Inc. (TSXV: ZCT) (OTCQB: ZCTFF) (FSE: 9L2) (the "Company" or "ZCT"), a FemTech medical device company revolutionizing... ► Artikel lesen | |
12.03. | Zero Candida Commences Trading on OTCQB Market | 316 | PR Newswire | VANCOUVER, BC, March 12, 2025 /PRNewswire/ -- Zero Candida Technologies, Inc. (TSXV: ZCT) (OTCQB: ZCTFF) (FSE: 9L2) (the "Company" or "ZCT"), a FemTech medical device company revolutionizing... ► Artikel lesen | |
03.02. | Moore Market analysis: Zero Candida potential market will reach over $2 Billion by 2030 | 212 | PR Newswire | According to the report: up to 75% of women will have at least one vaginal yeast infection in their life
VANCOUVER, BC, Feb. 3, 2025 /PRNewswire/ -- A market analysis made by Moore... ► Artikel lesen | |
17.01. | Zero Candida Technologies Inc: Zero Candida lists shares on the Frankfurt exchange | 1 | Stockwatch | ||
16.01. | Zero Candida Announces Successful Listing on Frankfurt Stock Exchange and Details of Investor Webinar | 426 | PR Newswire | VANCOUVER, BC, Jan. 16, 2025 /PRNewswire/ -- Zero Candida Technologies, Inc. (TSXV: ZCT) (FSE: 9L2) (the "Company" or "ZCT"), an Israeli FemTech medical device company focused on revolutionizing... ► Artikel lesen | |
07.01. | Zero Candida Technologies Inc: Zero Candida plans to finish preclinical studies by Q3 | 1 | Stockwatch | ||
06.01. | Zero Candida Announces Plans to Complete Preclinical Studies for FDA Submission by Q3 2025 | 333 | PR Newswire | VANCOUVER, BC, Jan. 6, 2025 /PRNewswire/ -- Zero Candida Technologies, Inc. (TSXV: ZCT), (FSE: 9L2) (the "Company" or "ZCT"), an Israeli FemTech medical device company focused on revolutionizing... ► Artikel lesen | |
16.12.24 | XFRA NEW INSTRUMENTS AVAILABLE ON XETRA - 16.12.2024 | 793 | Xetra Newsboard | The following instruments on XETRA do have their first trading 16.12.2024 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 16.12.2024
Aktien
1 CA74767K1030 Quantum eMotion Corp.
2... ► Artikel lesen | |
09.12.24 | Zero Candida Receives South African Patent for its ZC- 01 device | 303 | PR Newswire | Announces IP plans to obtain a worldwide patent portfolio in 2025
VANCOUVER, BC, Dec. 9, 2024 /PRNewswire/ -- Zero Candida (the "Company" or "ZC") (TSXV: ZCT), an Israeli FemTech medical... ► Artikel lesen | |
25.11.24 | Toronto Stock Exchange: Zero Candida Technologies Inc. (ZCT) Opens the Market | 578 | Newsfile | Toronto, Ontario--(Newsfile Corp. - November 25, 2024) - Eli Ben-Haroosh, Co-Founder and Chief Executive Officer, Zero Candida Technologies Inc. (TSXV: ZCT) ("Zero Candida" or the "Company"), joined... ► Artikel lesen | |
25.11.24 | Zero Candida Announces Full Transaction and Being Trading November 25th on the TSX Venture Exchange (Canada) | 478 | PR Newswire | VANCOUVER, BC, Nov. 25, 2024 /PRNewswire/ -- Zero Candida (the "Company" or "ZCT"), (TSXV: ZCT) an Israeli FemTech medical device start-up, is pleased to announce full Transaction and Being... ► Artikel lesen | |
21.11.24 | Zero Candida Announces TSX Venture Exchange Listing Date | 528 | PR Newswire | VANCOUVER, BC, Nov. 21, 2024 /PRNewswire/ -- Zero Candida Technologies Inc. (the "Company" or "Zero Candida") (TSXV: ZCT), a technology company focused on development and commercial exploitation... ► Artikel lesen | |
18.11.24 | Zero Candida Applies to List its Shares on the TSX Venture Exchange | 271 | PR Newswire | VANCOUVER, BC, Nov. 18, 2024 /PRNewswire/ -- Zero Candida Technologies Inc. (the "Company" or "Zero Candida") (TSXV: ZCT), a technology company focused on development and commercial exploitation... ► Artikel lesen | |
26.08.24 | Zero Candida Announces Launch of New Website | 355 | PR Newswire | Company is in the Process of Being Listed on the TSX Venture Exchange (Canada) at a Proposed Valuation of 40 Million Canadian Dollars
VANCOUVER, BC, Aug. 26, 2024 /PRNewswire/ -- Zero... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
SIEMENS HEALTHINEERS | 46,840 | -0,28 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
FRESENIUS MEDICAL CARE | 48,050 | +1,18 % | BERENBERG stuft FMC FRESENIUS MEDICAL CARE AG auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat das Kursziel für Fresenius Medical Care (FMC) von 55 auf 60 Euro angehoben und die Einstufung auf "Buy" belassen. Analystin Victoria Lambert... ► Artikel lesen | |
FRESENIUS | 42,190 | +0,57 % | EQS-PVR: Fresenius SE & Co. KGaA: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Stimmrechtsmitteilung: Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
20.06.2025 /... ► Artikel lesen | |
PROGYNY | 21,460 | 0,00 % | Here's Why Progyny (PGNY) Rebounded in Q1 | ||
PROCEPT BIOROBOTICS | 58,63 | 0,00 % | PROCEPT BioRobotics Reports Fourth Quarter and Full Year 2024 Results | SAN JOSE, Calif., Feb. 25, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
PRIVIA HEALTH GROUP | 22,000 | +1,20 % | Privia Health Group, Inc.: Privia Health Reports First Quarter 2025 Financial Results | Strong First Quarter Performance and Operating ExecutionEnters the State of ArizonaFull-Year 2025 Outlook Raised to Mid- to High End of Guidance Ranges for All Metrics with Attributed Lives Unchanged... ► Artikel lesen | |
ADAPTHEALTH | 9,420 | +4,55 % | AdaptHealth Corp. - 10-K/A, Annual Report | ||
CARL ZEISS MEDITEC | 56,40 | -1,57 % | Aktienmarkt: Aktie von Carl Zeiss Meditec kann sich nicht behaupten (56,30 €) | Im deutschen Wertpapierhandel liegt die Carl Zeiss Meditec-Aktie gegenwärtig im Minus. Das Wertpapier kostete zuletzt 56,30 Euro. Ein Wertverlust in Höhe von 1,75 Euro müssen derzeit die Aktionäre von... ► Artikel lesen | |
GERRESHEIMER | 47,480 | +1,24 % | Deutsche Pfandbriefbank, Gerresheimer, Hugo Boss, Renk, Rheinmetall, Symrise - Aktien-Positionen der Short-Seller | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
PHETON | 17,540 | 0,00 % | Pheton Holdings Ltd - S-8, Securities to be offered to employees in employee benefit plans | ||
RXSIGHT | 13,230 | 0,00 % | RxSight, Inc. Announces Preliminary First Quarter 2025 Revenue and Revised 2025 Guidance | ALISO VIEJO, Calif., April 02, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) - RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following... ► Artikel lesen | |
LIFEMD | 13,540 | 0,00 % | LifeMD-Aktie steigt nach Fortsetzung der Wegovy-Partnerschaft mit Novo Nordisk | ||
ALIGNMENT HEALTHCARE | 13,760 | 0,00 % | Alignment Healthcare Reports Strong First Quarter 2025 Results; Exceeds High-End of Expectations On 4 Critical KPIs; Raises Midpoint of 2025 Guidance; Announces CFO Transition | Delivers Q1 revenue of $926.9 million, up 47.5% year over year, and grows Medicare Advantage (MA) membership by 31.7% to approximately 217,500 membersExceeds high-end of Q1 guidance on membership... ► Artikel lesen | |
GENEDX | 89,52 | +0,65 % | Agents become digital coworkers: Sema4.ai powers the next phase of enterprise AI | ||
BRIGHTSPRING HEALTH SERVICES | 23,060 | +2,04 % | TD Cowen Begins Coverage of BrightSpring Health Services (BTSG) Stock, Gives Buy |